A detailed history of Msa Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Msa Advisors, LLC holds 3,500 shares of NVO stock, worth $376,705. This represents 0.14% of its overall portfolio holdings.

Number of Shares
3,500
Previous 3,500 -0.0%
Holding current value
$376,705
Previous $452 Million 10.6%
% of portfolio
0.14%
Previous 0.14%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $307,230 - $369,075
3,500 New
3,500 $362 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $243B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Msa Advisors, LLC Portfolio

Follow Msa Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Msa Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Msa Advisors, LLC with notifications on news.